Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Systematic Review Article

Drug-induced Sudden Death: A Scoping Review

Author(s): Kristopher Amaro-Hosey, Xavier Castells*, Lidia Blanco-Silvente, Pablo Loma-Osorio and Dolors Capellà

Volume 18, Issue 3, 2023

Published on: 15 August, 2022

Page: [307 - 317] Pages: 11

DOI: 10.2174/1574886317666220525115232

Price: $65

Abstract

Background: The risk of sudden cardiac death (SCD) can be increased with the use of drugs. However, it has been described heterogeneously in the literature.

Objective: This study aims to systematically review epidemiological studies dealing with druginduced sudden death, describe their methodologies, and summarize the results found.

Methods: A scoping review has been carried out using Medline electronic database. The search was limited up to 2020. Epidemiological studies were included, and case reports or case series were excluded.

Results: Out of 3,114 potential articles, 74 were included. Most studies originated from North America (40.5%) or Europe (39.2%). Case-control (47.3%) or cohort (40.5%) studies were the most common designs. The data for outcomes and exposure were retrieved mainly from administrative databases (37.8%) or medical charts/hospital discharge reports (32.4%), but most studies used several sources of information. A composite variable of sudden death or SCD, mainly with ventricular arrhythmia, was the most frequently used endpoint. Only 18.9% of the studies included autopsy results to confirm the death. Psychotropic drugs were the most frequently studied. An increased risk of different outcomes for typical antipsychotics, tricyclic antidepressants, domperidone, and antiepileptics is suggested.

Conclusion: The methodologies used were highly heterogeneous, and the results were, in general, not conclusive. An improvement of the methodologies is needed to achieve a conclusion regarding the risk of SCD associated with drug use.

Keywords: Sudden cardiac death, drug-induced, side effect, adverse drug reactions, epidemiological studies, scopes review.

[1]
Bayés de Luna A, Elosua R. Sudden death. Rev Esp Cardiol 2012; 65(11): 1039-52.
[http://dx.doi.org/10.1016/j.rec.2012.03.025] [PMID: 22959179]
[2]
Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98(21): 2334-51.
[http://dx.doi.org/10.1161/01.CIR.98.21.2334] [PMID: 9826323]
[3]
Straus SM, Bleumink GS, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC. The incidence of sudden cardiac death in the general population. J Clin Epidemiol 2004; 57(1): 98-102.
[http://dx.doi.org/10.1016/S0895-4356(03)00210-5] [PMID: 15019016]
[4]
Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992; 85(1) (Suppl.): I2-I10.
[PMID: 1728501]
[5]
Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002; 62(11): 1649-71.
[http://dx.doi.org/10.2165/00003495-200262110-00006] [PMID: 12109926]
[6]
Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006; 47(2): 362-7.
[http://dx.doi.org/10.1016/j.jacc.2005.08.067] [PMID: 16412861]
[7]
Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf 2008; 7(2): 181-94.
[http://dx.doi.org/10.1517/14740338.7.2.181] [PMID: 18324881]
[8]
Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350(10): 1013-22.
[http://dx.doi.org/10.1056/NEJMra032426] [PMID: 14999113]
[9]
Glassman AH, Bigger JT Jr. Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158(11): 1774-82.
[http://dx.doi.org/10.1176/appi.ajp.158.11.1774] [PMID: 11691681]
[10]
Enger C, Cali C, Walker AM. Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidemiol Drug Saf 2002; 11(6): 477-86.
[http://dx.doi.org/10.1002/pds.725] [PMID: 12426932]
[11]
Food and Drug Administration (FDA). FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. 2012. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-revised-recommendations-celexa-citalopram-hydrobromide-related (Accessed on 2022 May 12).
[12]
Food and Drug Administration (FDA). FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms. 2013. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-azithromycin-zithromax-or-zmax-and-risk-potentially-fatal-heart (Accessed on 2022 May 12).
[13]
Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 2018; 169(7): 467-73.
[http://dx.doi.org/10.7326/M18-0850] [PMID: 30178033]
[14]
Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992; 20(3): 527-32.
[http://dx.doi.org/10.1016/0735-1097(92)90003-6] [PMID: 1512329]
[15]
Hoes AW, Grobbee DE, Peet TM, Lubsen J. Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence. Drugs 1994; 47(5): 711-33.
[http://dx.doi.org/10.2165/00003495-199447050-00002] [PMID: 7520854]
[16]
Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moyé L. Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol 1994; 73(5): 346-52.
[http://dx.doi.org/10.1016/0002-9149(94)90006-X] [PMID: 8109548]
[17]
Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330(26): 1852-7.
[http://dx.doi.org/10.1056/NEJM199406303302603] [PMID: 8196728]
[18]
Hanrahan JP, Choo PW, Carlson W, Greineder D, Faich GA, Platt R. Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization. Ann Epidemiol 1995; 5(3): 201-9.
[http://dx.doi.org/10.1016/1047-2797(94)00039-V] [PMID: 7606309]
[19]
Hoes AW, Grobbee DE, Lubsen J, Man in ’t Veld AJ, van der Does E, Hofman A. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 1995; 123(7): 481-7.
[http://dx.doi.org/10.7326/0003-4819-123-7-199510010-00001] [PMID: 7661490]
[20]
Staffa JA, Jones JK, Gable CB, Verspeelt JP, Amery WK. Risk of selected serious cardiac events among new users of antihistamines. Clin Ther 1995; 17(6): 1062-77.
[http://dx.doi.org/10.1016/0149-2918(95)80085-9] [PMID: 8750398]
[21]
Middlekauff HR, Stevenson WG, Saxon LA, Stevenson LW. Amiodarone and torsades de pointes in patients with advanced heart failure. Am J Cardiol 1995; 76(7): 499-502.
[http://dx.doi.org/10.1016/S0002-9149(99)80138-6] [PMID: 7653452]
[22]
Jonville-Bera AP, Autret E, Laugier J. Sudden infant death syndrome and diphtheria-tetanus-pertussis-poliomyelitis vaccination status. Fundam Clin Pharmacol 1995; 9(3): 263-70.
[http://dx.doi.org/10.1111/j.1472-8206.1995.tb00294.x] [PMID: 7557822]
[23]
Biederman J, Thisted RA, Greenhill LL, Ryan ND. Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children. J Clin Psychiatry 1995; 56(3): 87-93.
[PMID: 7883735]
[24]
Carvajal A, Caro-Patón T, Martín de Diego I, Martín Arias LH, Alvarez Requejo A, Lobato A. DTP vaccine and infant sudden death syndrome. Meta-analysis. Med Clin 1996; 106(17): 649-52.
[PMID: 8691909]
[25]
Walker AM, Szneke P, Weatherby LB, et al. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med 1999; 107(4): 356-62.
[http://dx.doi.org/10.1016/S0002-9343(99)00241-7] [PMID: 10527038]
[26]
Modai I, Hirschmann S, Rava A, et al. Sudden death in patients receiving clozapine treatment: A preliminary investigation. J Clin Psychopharmacol 2000; 20(3): 325-7.
[http://dx.doi.org/10.1097/00004714-200006000-00006] [PMID: 10831019]
[27]
Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58(12): 1161-7.
[http://dx.doi.org/10.1001/archpsyc.58.12.1161] [PMID: 11735845]
[28]
Walczak TS, Leppik IE, D’Amelio M, et al. Incidence and risk factors in sudden unexpected death in epilepsy: A prospective cohort study. Neurology 2001; 56(4): 519-25.
[http://dx.doi.org/10.1212/WNL.56.4.519] [PMID: 11222798]
[29]
Nilsson L, Bergman U, Diwan V, Farahmand BY, Persson PG, Tomson T. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: A case-control study. Epilepsia 2001; 42(5): 667-73.
[http://dx.doi.org/10.1046/j.1528-1157.2001.22000.x] [PMID: 11380576]
[30]
Jonville-Béra AP, Autret-Leca E, Barbeillon F, Paris-Llado J. Sudden unexpected death in infants under 3 months of age and vaccination status -a case-control study. Br J Clin Pharmacol 2001; 51(3): 271-6.
[http://dx.doi.org/10.1046/j.1365-2125.2001.00341.x] [PMID: 11298074]
[31]
Hennessy S, Bilker WB, Knauss JS, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data. BMJ 2002; 325(7372): 1070.
[http://dx.doi.org/10.1136/bmj.325.7372.1070] [PMID: 12424166]
[32]
Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry 2002; 180: 515-22.
[http://dx.doi.org/10.1192/bjp.180.6.515] [PMID: 12042230]
[33]
Wang PS, Levin R, Zhao SZ, Avorn J. Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients. J Am Geriatr Soc 2002; 50(1): 117-24.
[http://dx.doi.org/10.1046/j.1532-5415.2002.50017.x] [PMID: 12028256]
[34]
Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004; 75(3): 234-41.
[http://dx.doi.org/10.1016/j.clpt.2003.09.019] [PMID: 15001975]
[35]
Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004; 351(11): 1089-96.
[http://dx.doi.org/10.1056/NEJMoa040582] [PMID: 15356306]
[36]
Straus SM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004; 164(12): 1293-7.
[http://dx.doi.org/10.1001/archinte.164.12.1293] [PMID: 15226162]
[37]
Liperoti R, Gambassi G, Lapane KL, et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med 2005; 165(6): 696-701.
[http://dx.doi.org/10.1001/archinte.165.6.696] [PMID: 15795349]
[38]
Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J 2005; 26(19): 2007-12.
[http://dx.doi.org/10.1093/eurheartj/ehi312] [PMID: 15888497]
[39]
Hubbard R, Lewis S, West J, et al. Bupropion and the risk of sudden death: A self-controlled case-series analysis using the health improvement network. Thorax 2005; 60(10): 848-50.
[http://dx.doi.org/10.1136/thx.2005.041798] [PMID: 16055620]
[40]
Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: Nested case-control study. Lancet 2005; 365(9458): 475-81.
[http://dx.doi.org/10.1016/S0140-6736(05)17864-7] [PMID: 15705456]
[41]
Velentgas P, West W, Cannuscio CC, Watson DJ, Walker AM. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications. Pharmacoepidemiol Drug Saf 2006; 15(9): 641-52.
[http://dx.doi.org/10.1002/pds.1192] [PMID: 16392153]
[42]
De Bruin ML, Langendijk PN, Koopmans RP, Wilde AA, Leufkens HG, Hoes AW. In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol 2007; 63(2): 216-23.
[http://dx.doi.org/10.1111/j.1365-2125.2006.02722.x] [PMID: 16869820]
[43]
Chugh SS, Socoteanu C, Reinier K, Waltz J, Jui J, Gunson K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med 2008; 121(1): 66-71.
[http://dx.doi.org/10.1016/j.amjmed.2007.10.009] [PMID: 18187075]
[44]
Hennessy S, Leonard CE, Newcomb C, Kimmel SE, Bilker WB. Cisapride and ventricular arrhythmia. Br J Clin Pharmacol 2008; 66(3): 375-85.
[http://dx.doi.org/10.1111/j.1365-2125.2008.03249.x] [PMID: 18662288]
[45]
Gould MS, Walsh BT, Munfakh JL, et al. Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166(9): 992-1001.
[http://dx.doi.org/10.1176/appi.ajp.2009.09040472] [PMID: 19528194]
[46]
Jolly K, Gammage MD, Cheng KK, Bradburn P, Banting MV, Langman MJ. Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol 2009; 68(5): 743-51.
[http://dx.doi.org/10.1111/j.1365-2125.2009.03496.x] [PMID: 19916999]
[47]
McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. Mortality associated with Attention-Deficit Hyperactivity Disorder (ADHD) drug treatment: A retrospective cohort study of children, adolescents and young adults using the general practice research database. Drug Saf 2009; 32(11): 1089-96.
[http://dx.doi.org/10.2165/11317630-000000000-00000] [PMID: 19810780]
[48]
Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360(3): 225-35.
[http://dx.doi.org/10.1056/NEJMoa0806994] [PMID: 19144938]
[49]
van Noord C, Sturkenboom MC, Straus SM, Hofman A, Witteman JC, Stricker BH. Population-based studies of antithyroid drugs and sudden cardiac death. Br J Clin Pharmacol 2009; 68(3): 447-54.
[http://dx.doi.org/10.1111/j.1365-2125.2009.03474.x] [PMID: 19740403]
[50]
Zambon A, Polo Friz H, Contiero P, Corrao G. Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: An observational study in Italy using case-control, case-crossover and case-time-control designs. Drug Saf 2009; 32(2): 159-67.
[http://dx.doi.org/10.2165/00002018-200932020-00008] [PMID: 19236122]
[51]
Johannes CB, Varas-Lorenzo C, McQuay LJ, Midkiff KD, Fife D. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: A nested case-control study. Pharmacoepidemiol Drug Saf 2010; 19(9): 881-8.
[http://dx.doi.org/10.1002/pds.2016] [PMID: 20652862]
[52]
Martinez C, Assimes TL, Mines D, Dell’aniello S, Suissa S. Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: A nested case-control study. BMJ 2010; 340: c249.
[http://dx.doi.org/10.1136/bmj.c249] [PMID: 20139216]
[53]
van Noord C, Dieleman JP, van Herpen G, Verhamme K, Sturkenboom MC. Domperidone and ventricular arrhythmia or sudden cardiac death: A population-based case-control study in the Netherlands. Drug Saf 2010; 33(11): 1003-14.
[http://dx.doi.org/10.2165/11536840-000000000-00000] [PMID: 20925438]
[54]
Weeke P, Folke F, Gislason GH, et al. Pharmacotherapy and hospital admissions before out-of-hospital cardiac arrest: A nationwide study. Resuscitation 2010; 81(12): 1657-63.
[http://dx.doi.org/10.1016/j.resuscitation.2010.06.025] [PMID: 20727660]
[55]
Almroth H, Andersson T, Fengsrud E, et al. The safety of flecainide treatment of atrial fibrillation: Long-term incidence of sudden cardiac death and proarrhythmic events. J Intern Med 2011; 270(3): 281-90.
[http://dx.doi.org/10.1111/j.1365-2796.2011.02395.x] [PMID: 21635583]
[56]
Geier JL, Karayal ON, Lewis M, et al. Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). Pharmacoepidemiol Drug Saf 2011; 20(11): 1192-8.
[http://dx.doi.org/10.1002/pds.2185] [PMID: 21796719]
[57]
Leonard CE, Bilker WB, Newcomb C, Kimmel SE, Hennessy S. Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia. Pharmacoepidemiol Drug Saf 2011; 20(9): 903-13.
[http://dx.doi.org/10.1002/pds.2181] [PMID: 21796718]
[58]
Schelleman H, Bilker WB, Strom BL, et al. Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 2011; 127(6): 1102-10.
[http://dx.doi.org/10.1542/peds.2010-3371] [PMID: 21576311]
[59]
Strom BL, Eng SM, Faich G, et al. Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). Am J Psychiatry 2011; 168(2): 193-201.
[http://dx.doi.org/10.1176/appi.ajp.2010.08040484] [PMID: 21041245]
[60]
van Noord C, Sturkenboom MC, Straus SM, Witteman JC, Stricker BH. Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death. Heart 2011; 97(3): 215-20.
[http://dx.doi.org/10.1136/hrt.2009.188367] [PMID: 20406763]
[61]
Honkola J, Hookana E, Malinen S, et al. Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J 2012; 33(6): 745-51.
[http://dx.doi.org/10.1093/eurheartj/ehr368] [PMID: 21920969]
[62]
Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012; 366(20): 1881-90.
[http://dx.doi.org/10.1056/NEJMoa1003833] [PMID: 22591294]
[63]
Schelleman H, Bilker WB, Kimmel SE, et al. Methylphenidate and risk of serious cardiovascular events in adults. Am J Psychiatry 2012; 169(2): 178-85.
[http://dx.doi.org/10.1176/appi.ajp.2011.11010125] [PMID: 22318795]
[64]
Weeke P, Jensen A, Folke F, et al. Antidepressant use and risk of out-of-hospital cardiac arrest: A nationwide case-time-control study. Clin Pharmacol Ther 2012; 92(1): 72-9.
[http://dx.doi.org/10.1038/clpt.2011.368] [PMID: 22588605]
[65]
Hesdorffer DC, Tomson T, Benn E, et al. Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 2012; 53(2): 249-52.
[http://dx.doi.org/10.1111/j.1528-1167.2011.03354.x] [PMID: 22191685]
[66]
Aurlien D, Larsen JP, Gjerstad L, Taubøll E. Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: A nested, case-control study. Epilepsia 2012; 53(2): 258-66.
[http://dx.doi.org/10.1111/j.1528-1167.2011.03334.x] [PMID: 22126371]
[67]
Bardai A, Amin AS, Blom MT, et al. Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: Evidence from bench, bedside, and community. Eur Heart J 2013; 34(20): 1506-16.
[http://dx.doi.org/10.1093/eurheartj/eht054] [PMID: 23425522]
[68]
Jones ME, Campbell G, Patel D, et al. Risk of mortality (including sudden cardiac death) and major cardiovascular events in users of olanzapine and other antipsychotics: A study with the general practice research database. Cardiovasc Psychiatry Neurol 2013; 2013: 647476.
[http://dx.doi.org/10.1155/2013/647476] [PMID: 24416588]
[69]
Leonard CE, Freeman CP, Newcomb CW, et al. Antipsychotics and the risks of sudden cardiac death and all-cause death: Cohort studies in medicaid and dually-eligible medicaid-medicare beneficiaries of five states. J Clin Exp Cardiolog 2013; Suppl 10(6): 1-9.
[70]
Ray WA, Murray KT, Kawai V, et al. Propoxyphene and the risk of out-of-hospital death. Pharmacoepidemiol Drug Saf 2013; 22(4): 403-12.
[http://dx.doi.org/10.1002/pds.3411] [PMID: 23408551]
[71]
Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. CMAJ 2015; 187(4): E138-43.
[http://dx.doi.org/10.1503/cmaj.140816] [PMID: 25646289]
[72]
Arana A, Johannes CB, McQuay LJ, Varas-Lorenzo C, Fife D, Rothman KJ. Risk of out-of-hospital sudden cardiac death in users of domperidone, proton pump inhibitors, or metoclopramide: A population-based nested case-control study. Drug Saf 2015; 38(12): 1187-99.
[http://dx.doi.org/10.1007/s40264-015-0338-0] [PMID: 26350642]
[73]
Bardai A, Blom MT, van Noord C, Verhamme KM, Sturkenboom MC, Tan HL. Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications. Heart 2015; 101(1): 17-22.
[http://dx.doi.org/10.1136/heartjnl-2014-305664] [PMID: 25031263]
[74]
Marzi M, Weitz D, Avila A, Molina G, Caraballo L, Piskulic L. Cardiac adverse effects of domperidone in adult patients: A systematic review. Rev Med Chil 2015; 143(1): 14-21.
[http://dx.doi.org/10.4067/S0034-98872015000100002] [PMID: 25860264]
[75]
Niemeijer MN, van den Berg ME, Deckers JW, et al. ABCB1 gene variants, digoxin and risk of sudden cardiac death in a general population. Heart 2015; 101(24): 1973-9.
[http://dx.doi.org/10.1136/heartjnl-2014-307419] [PMID: 26531821]
[76]
Hou PY, Hung GC, Jhong JR, Tsai SY, Chen CC, Kuo CJ. Risk factors for sudden cardiac death among patients with schizophrenia. Schizophr Res 2015; 168(1-2): 395-401.
[http://dx.doi.org/10.1016/j.schres.2015.07.015] [PMID: 26210551]
[77]
Leelakanok N, Holcombe A, Schweizer ML. Domperidone and risk of ventricular arrhythmia and cardiac death: A systematic review and meta-analysis. Clin Drug Investig 2016; 36(2): 97-107.
[http://dx.doi.org/10.1007/s40261-015-0360-0] [PMID: 26649742]
[78]
Renoux C, Dell’Aniello S, Khairy P, et al. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s disease. Br J Clin Pharmacol 2016; 82(2): 461-72.
[http://dx.doi.org/10.1111/bcp.12964] [PMID: 27062307]
[79]
Salvo F, Pariente A, Shakir S, et al. Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies. Clin Pharmacol Ther 2016; 99(3): 306-14.
[http://dx.doi.org/10.1002/cpt.250] [PMID: 26272741]
[80]
Huang WT, Chen RT, Hsu YC, Glasser JW, Rhodes PH. Vaccination and unexplained sudden death risk in Taiwanese infants. Pharmacoepidemiol Drug Saf 2017; 26(1): 17-25.
[http://dx.doi.org/10.1002/pds.4141] [PMID: 27891698]
[81]
Alharbi FF, Souverein PC, de Groot MCH, et al. The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study. Br J Clin Pharmacol 2017; 83(11): 2541-8.
[http://dx.doi.org/10.1111/bcp.13356] [PMID: 28662543]
[82]
Ray WA, Chung CP, Murray KT, Hall K, Stein CM. High-dose citalopram and escitalopram and the risk of out-of-hospital death. J Clin Psychiatry 2017; 78(2): 190-5.
[http://dx.doi.org/10.4088/JCP.15m10324] [PMID: 27736049]
[83]
Quinn KL, Macdonald EM, Gomes T, Mamdani MM, Huang A, Juurlink DN. Macrolides, digoxin toxicity and the risk of sudden death: A population-based study. Drug Saf 2017; 40(9): 835-40.
[http://dx.doi.org/10.1007/s40264-017-0539-9] [PMID: 28421551]
[84]
Leonard CE, Brensinger CM, Aquilante CL, et al. Comparative safety of sulfonylureas and the risk of sudden cardiac arrest and ventricular arrhythmia. Diabetes Care 2018; 41(4): 713-22.
[http://dx.doi.org/10.2337/dc17-0294] [PMID: 29437823]
[85]
Dhopeshwarkar N, Brensinger CM, Bilker WB, et al. Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations. Sci Rep 2020; 10(1): 10070.
[http://dx.doi.org/10.1038/s41598-020-66668-5] [PMID: 32572080]
[86]
Simpson TF, Salazar JW, Vittinghoff E, et al. Association of QT-prolonging medications with risk of autopsy-defined causes of sudden death. JAMA Intern Med 2020; 180(5): 698-706.
[http://dx.doi.org/10.1001/jamainternmed.2020.0148] [PMID: 32119028]
[87]
Sveinsson O, Andersson T, Mattsson P, Carlsson S, Tomson T. Pharmacologic treatment and SUDEP risk: A nationwide, population-based, case-control study. Neurology 2020; 95(18): e2509-18.
[http://dx.doi.org/10.1212/WNL.0000000000010874] [PMID: 32967928]
[88]
Iseri LT, Humphrey SB, Siner EJ. Prehospital brady-asystolic cardiac arrest. Ann Intern Med 1978; 88(6): 741-5.
[http://dx.doi.org/10.7326/0003-4819-88-6-741] [PMID: 352211]
[89]
Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 2002; 288(23): 3008-13.
[http://dx.doi.org/10.1001/jama.288.23.3008] [PMID: 12479765]
[90]
Nichol G, Sayre MR, Guerra F, Poole J. Defibrillation for ventricular fibrillation: A shocking update. J Am Coll Cardiol 2017; 70(12): 1496-509.
[http://dx.doi.org/10.1016/j.jacc.2017.07.778] [PMID: 28911514]
[91]
Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of the death certificate. N Engl J Med 1985; 313(20): 1263-9.
[http://dx.doi.org/10.1056/NEJM198511143132005] [PMID: 4058507]
[92]
Chung CP, Murray KT, Stein CM, Hall K, Ray WA. A computer case definition for sudden cardiac death. Pharmacoepidemiol Drug Saf 2010; 19(6): 563-72.
[http://dx.doi.org/10.1002/pds.1888] [PMID: 20029823]
[93]
Qi Y, Song D, Chen Y. Colorimetric oligonucleotide-based sensor for ultra-low Hg2+ in contaminated environmental medium: Convenience, sensitivity and mechanism. Sci Total Environ 2021; 766: 142579.
[http://dx.doi.org/10.1016/j.scitotenv.2020.142579] [PMID: 33601667]
[94]
Song Z, Xiu FR, Qi Y. Degradation and partial oxidation of waste plastic express packaging bags in supercritical water: Resources transformation and pollutants removal. J Hazard Mater 2022; 423(Pt A): 127018.
[95]
Bañeras J, Ferreira-González I, Marsal JR, et al. Short-term exposure to air pollutants increases the risk of ST elevation myocardial infarction and of infarct-related ventricular arrhythmias and mortality. Int J Cardiol 2018; 250: 35-42.
[http://dx.doi.org/10.1016/j.ijcard.2017.10.004] [PMID: 29056239]
[96]
Tomlinson G, Detsky AS. Composite end points in randomized trials: There is no free lunch. JAMA 2010; 303(3): 267-8.
[http://dx.doi.org/10.1001/jama.2009.2017] [PMID: 20085955]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy